Member access

4-Traders Homepage  >  Shares  >  Xetra  >  CytoTools AG    T5O   DE000A0KFRJ1

CYTOTOOLS AG (T5O)

7
Real-time Quote. Real-time Tradegate - 03/27 12:33:28 pm
43.7 EUR   -4.77%
03/11 CYTOTOOLS : Updates on European studies and approval status in India..
2014 CYTOTOOLS : DermaPro
2014 CYTOTOOLS : Clinical development
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Xetra
03/23/2015 03/24/2015 03/25/2015 03/26/2015 03/27/2015 Date
46.5(c) 43.03(c) 46.7(c) 45.89(c) 44.3(c) Last
1 180 3 565 3 881 305 927 Volume
-0.85% -7.46% +8.53% -1.73% -3.46% Change
More quotes
Financials (€)
Sales 2014 1,94 M
EBIT 2014 -1,74 M
Net income 2014 -0,92 M
Finance 2014 2,50 M
Yield 2014 -
Sales 2015 6,63 M
EBIT 2015 2,68 M
Net income 2015 1,22 M
Finance 2015 1,80 M
Yield 2015 -
PER 2014 -
PER 2015 71,30
EV / Sales 2014 44,4x
EV / Sales 2015 13,1x
Capitalization 88,7 M
More Financials
Company
CytoTools AG operates as a technology and associated company, which is engaged in the purchase, management and sale of shareholdings in German technology enterprises.It focuses on investing in enterprises from the health sector, active in the area of research and development of medicaments and... 
More about the company
Surperformance© ratings of CytoTools AG
Trading Rating : - Investor Rating :
More Ratings
Latest news on CYTOTOOLS AG
03/11 CYTOTOOLS : Updates on European studies and approval status in India.pdf
03/04 CYTOTOOLS : Europäische Studien zum diabetischen Fuß und offenen Bein im Zeitpla..
2014 CYTOTOOLS : DermaPro
2014 CYTOTOOLS : Clinical development
2014 CYTOTOOLS : Clinical development of wound healing drug DermaPro(R) progressing o..
2014 CYTOTOOLS : Annual General Meeting 2014
2014 CYTOTOOLS : Annual General Meeting elects new Supervisory Board members (DGAP Ne..
2014 CYTOTOOLS : Capital Increase CytoPharma GmbH
More news
Sector news : Bio Therapeutic Drugs
08:36a ISIS PHARMACEUTICALS : Earnings Coverage - Isis Pharma
03/26 Alliance invokes Elliott track record in appeal against board shake-up
03/26 ACTELION : receives marketing approval for Opsumit (macitentan) in pulmonary art..
More sector news : Bio Therapeutic Drugs


Comments 
Advertisement
Chart CYTOTOOLS AG
Duration : Period :
CytoTools AG Technical Analysis Chart | T5O | DE000A0KFRJ1 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF